Does LERCANIDIPINE Cause Electrocardiogram qt prolonged? 47 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Electrocardiogram qt prolonged have been filed in association with LERCANIDIPINE. This represents 1.3% of all adverse event reports for LERCANIDIPINE.
47
Reports of Electrocardiogram qt prolonged with LERCANIDIPINE
1.3%
of all LERCANIDIPINE reports
1
Deaths
20
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From LERCANIDIPINE?
Of the 47 reports, 1 (2.1%) resulted in death, 20 (42.6%) required hospitalization, and 34 (72.3%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LERCANIDIPINE. However, 47 reports have been filed with the FAERS database.
What Other Side Effects Does LERCANIDIPINE Cause?
Acute kidney injury (424)
Hypotension (401)
Fall (323)
Hypertension (197)
Hyperkalaemia (176)
Drug ineffective (149)
Diarrhoea (122)
Hyponatraemia (122)
Renal impairment (120)
Oedema peripheral (114)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which LERCANIDIPINE Alternatives Have Lower Electrocardiogram qt prolonged Risk?
LERCANIDIPINE vs LETAIRIS
LERCANIDIPINE vs LETERMOVIR
LERCANIDIPINE vs LETROZOLE
LERCANIDIPINE vs LETROZOLE\RIBOCICLIB
LERCANIDIPINE vs LEUCOVORIN